Download video

ESMO Congress 2025 Breast cancer, early stage Track – Programme Highlights

No views

European Society for Medical Oncology (ESMO)

13 hours ago

ESMO Congress 2025 Breast cancer, early stage Track – Programme Highlights

ESMO Congress 2025 Breast cancer, early stage Track – Programme Highlights

ESMO 2025 Top 10 Breast Cancer Abstracts from Paolo Tarantino, MD
2:19
ESMO 2025 Top 10 Breast Cancer Abstracts from Paolo Tarantino, MD
by OncologyTube
#ESMO22 Highlights on abemaciclib + NSAI in HR+\/HER2- advanced breast cancer: The MONARCH 3 study
2:37
#ESMO22 Highlights on abemaciclib + NSAI in HR+\/HER2- advanced breast cancer: The MONARCH 3 study
by European Society for Medical Oncology (ESMO)
Metastatic breast cancer at ESMO 2022: TROPiCS02, MONARCH 3 and SYNERGY
5:37
Metastatic breast cancer at ESMO 2022: TROPiCS02, MONARCH 3 and SYNERGY
by VJOncology
Expert Video Report on biomarkers for immune checkpoint blockade in patients with solid tumours
3:41
Expert Video Report on biomarkers for immune checkpoint blockade in patients with solid tumours
by European Society for Medical Oncology (ESMO)
Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021
10:15
Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021
by European Society for Medical Oncology (ESMO)
Breast cancer research at ESMO 2021
1:19
Breast cancer research at ESMO 2021
by Dana-Farber Cancer Institute
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
5:32
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
by European Society for Medical Oncology (ESMO)
Introducing the ESMO Magnitude of Clinical Benefit Scale
0:58
Introducing the ESMO Magnitude of Clinical Benefit Scale
by European Society for Medical Oncology (ESMO)
ESMO Handbook of Immuno-Oncology
1:15
ESMO Handbook of Immuno-Oncology
by European Society for Medical Oncology (ESMO)
Highlights from ESMO Breast Cancer 2022
1:52
Highlights from ESMO Breast Cancer 2022
by VJOncology
#ESMO22 Highlights on pembrolizumab with CRT in locally advanced HNSCC: The KEYNOTE-412 study
2:17
#ESMO22 Highlights on pembrolizumab with CRT in locally advanced HNSCC: The KEYNOTE-412 study
by European Society for Medical Oncology (ESMO)
CANDO programme – towards better breast cancer treatment and recovery
5:27
CANDO programme – towards better breast cancer treatment and recovery
by World Cancer Research Fund